🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/10/2021 | 85,71 | 88,31 | 84,95 | 87,46 | +2,37% | 3,92% | 159.659 |
| 25/10/2021 | 84,97 | 85,70 | 83,54 | 85,43 | +0,48% | 2,55% | 123.752 |
| 22/10/2021 | 82,28 | 85,12 | 81,88 | 85,02 | +2,96% | 3,93% | 142.667 |
| 21/10/2021 | 81,83 | 83,31 | 81,25 | 82,58 | +0,74% | 2,52% | 103.073 |
| 20/10/2021 | 81,41 | 82,76 | 80,89 | 81,97 | +0,60% | 2,30% | 74.860 |
| 19/10/2021 | 80,70 | 82,91 | 80,67 | 81,48 | +1,59% | 2,77% | 82.394 |
| 18/10/2021 | 80,47 | 82,00 | 79,35 | 80,21 | -1,30% | 3,29% | 108.844 |
| 15/10/2021 | 82,16 | 82,48 | 81,03 | 81,26 | +0,39% | 1,76% | 114.935 |
| 14/10/2021 | 81,58 | 82,22 | 80,42 | 80,95 | +0,81% | 2,21% | 129.522 |
| 13/10/2021 | 80,06 | 81,38 | 78,97 | 80,30 | +0,46% | 3,01% | 98.585 |
| 12/10/2021 | 80,59 | 80,59 | 78,60 | 79,93 | -0,08% | 2,46% | 164.468 |
| 11/10/2021 | 79,73 | 82,13 | 79,38 | 79,99 | +0,37% | 3,44% | 135.133 |
| 08/10/2021 | 80,97 | 80,97 | 79,28 | 79,70 | -1,53% | 2,10% | 83.356 |
| 07/10/2021 | 79,85 | 83,09 | 79,85 | 80,94 | +1,50% | 4,06% | 153.728 |
| 06/10/2021 | 79,65 | 80,47 | 79,07 | 79,74 | -0,82% | 1,76% | 111.248 |
| 05/10/2021 | 79,54 | 81,92 | 79,54 | 80,40 | +0,93% | 2,99% | 137.537 |
| 04/10/2021 | 83,31 | 83,31 | 79,38 | 79,66 | -5,29% | 4,72% | 223.779 |
| 01/10/2021 | 86,69 | 86,69 | 82,45 | 84,10 | -3,23% | 4,90% | 322.684 |
| 30/09/2021 | 87,77 | 88,88 | 86,91 | 86,91 | -0,49% | 2,24% | 92.012 |
| 29/09/2021 | 86,71 | 88,15 | 85,75 | 87,34 | +1,41% | 2,78% | 160.781 |
| 28/09/2021 | 87,16 | 88,94 | 85,73 | 86,12 | -1,75% | 3,69% | 221.855 |
| 27/09/2021 | 86,84 | 88,58 | 86,41 | 87,65 | +0,96% | 2,50% | 142.667 |
| 24/09/2021 | 88,35 | 89,51 | 86,81 | 86,82 | -2,62% | 3,06% | 177.292 |
| 23/09/2021 | 89,56 | 89,84 | 87,41 | 89,16 | +0,57% | 2,71% | 127.919 |
| 22/09/2021 | 88,39 | 91,19 | 87,64 | 88,66 | +1,15% | 4,02% | 210.153 |
| 21/09/2021 | 85,95 | 87,77 | 85,03 | 87,65 | +2,79% | 3,19% | 142.186 |
| 20/09/2021 | 87,50 | 88,33 | 83,95 | 85,27 | -5,56% | 5,01% | 290.784 |
| 17/09/2021 | 84,55 | 90,68 | 83,97 | 90,29 | +7,22% | 7,93% | 722.793 |
| 16/09/2021 | 84,41 | 84,44 | 82,50 | 84,21 | -0,64% | 2,31% | 157.575 |
| 15/09/2021 | 82,76 | 84,76 | 81,20 | 84,75 | +2,89% | 4,30% | 201.177 |